Back to Capital Fund Management S.A. Capital Fund Management S.A.

TXGTXG

Showing 6 of 10 quarters

Position history for Capital Fund Management S.A.Capital Fund Management S.A.'s holdings in 10x Genomics, Inc.

No. Capital Fund Management exited its TXG (10x Genomics) position in Q4 2025. Its Q3 2025 13F listed 76,493 shares worth $894,203. Capital Fund Management first reported TXG in Q3 2021 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$5.1M

Total Shares Change

-223,668

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$16.31
0
2025-Q3
Decreased
76,493
-74.1%
$894,2030.0%$11.69
0
2025-Q2
Increased
295,188
+7.5%
$3.4M0.0%$11.58
29
2025-Q1
Decreased
274,461
-10.0%
$2.4M0.0%$8.73
0
2024-Q4
Increased
304,832
+36.3%
$4.4M0.0%$14.36
35
2024-Q3
New
223,668
—
$5.1M0.0%$22.67
37

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used